Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Innate Pharma (IPHA) Non Operating Income (2020 - 2022)

Historic Non Operating Income for Innate Pharma (IPHA) over the last 2 years, with Q4 2022 value amounting to -$557.06.

  • Innate Pharma's Non Operating Income changed N/A to -$557.06 in Q4 2022 from the same period last year, while for Dec 2022 it was -$6.7 million, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2024, which is 5901.87% down from last year.
  • According to the latest figures from Q4 2022, Innate Pharma's Non Operating Income is -$557.06.
  • In the past 5 years, Innate Pharma's Non Operating Income ranged from a high of -$557.06 in Q4 2022 and a low of -$2.3 million during Q4 2020